Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

CLINICAL-RESULTS OF AXILLOBIFEMORAL BYPASS USING EXTERNALLY - SUPPORTED POLYTETRAFLUOROETHYLENE 5TH ANNUAL MEETING OF THE WESTERN VASCULAR SOC Harris, E. J., Taylor, L. M., McConnell, D. B., Moneta, G. L., Yeager, R. A., Porter, J. M. MOSBY-YEAR BOOK INC. 1990: 416–21

Abstract

Seventy-six axillobifemoral grafts with externally supported polytetrafluoroethylene prostheses were performed since 1983. The indications for operation were absolute (aortic sepsis) in 20 (26%) patients and relative (excessive operative risk or technical difficulty) in 56 (74%) patients. The life-table primary patency for these operations at 4 years follow-up (mean follow-up, 2 years, 4 months) was 85%. We conclude that the patency results achieved in this patient series are sufficiently satisfactory to warrant use of axillobifemoral grafts in an expanded number of patients with high operative risk and need for bypass of aortoiliac occlusive disease.

View details for Web of Science ID A1990EE58200005

View details for PubMedID 2145447